paclitaxel (intraperitoneal and intravenous)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for paclitaxel (intraperitoneal and intravenous), covering 2018-10-31 to 2018-10-31. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Intraperitoneal and Intravenous Paclitaxel Plus Apatinib and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells [Phase 2]